Influencia de los virus respiratorios en la evaluación de la efectividad de la vacuna neumocócica de 13 serotipos en menores de 5 años: estudio de series temporales 2001-2013

Gentile, Ángela; Juarez, María del Valle; Luciön, María Florencia; Romanin, Viviana Sandra; Giglio, Norberto; Bakin, Julia.
Arch. argent. pediatr ; 113(4): 310-316, ago. 2015. graf, tab
Artigo em Inglês, Espanhol | LILACS, BINACIS | ID: lil-757042

Documentos relacionados

  1. Influence of respiratory viruses on the evaluation of the 13-valent pneumococcal conjugate vaccine effectiveness in children under 5 years old: A time-series study for the 2001-2013 period.
  2. Influencia de los virus respiratorios en la evaluación de la efectividad de la vacuna neumocócica de 13 serotipos en menores de 5 años: estudio de series temporales 2001-2013
  3. Noninvasive Streptococcus pneumoniae serotypes recovered from hospitalized adult patients in the United States in 2009 to 2012.
  4. Development of a novel flow cytometry method for detecting pneumococcal-specific B cells.
  5. Successful Control of Streptococcus pneumoniae 19A Replacement With a Catch-up Primary Vaccination Program in Taiwan.
  6. Frequency-dependent selection can forecast evolution in Streptococcus pneumoniae.
  7. Structural, Genetic, and Serological Elucidation of Streptococcus pneumoniae Serogroup 24 Serotypes: Discovery of a New Serotype, 24C, with a Variable Capsule Structure.
  8. Change in Pneumococcus Serotypes but not Mortality or Morbidity in Pre- and Post-13-Valent Polysaccharide Conjugate Vaccine Era: Epidemiology in a Pediatric Intensive Care Unit over 10 Years.
  9. Qualification and Clinical Validation of an Immunodiagnostic Assay for Detecting 11 Additional Streptococcus pneumoniae Serotype-specific Polysaccharides in Human Urine.
  10. Near-elimination of otitis media caused by 13-valent pneumococcal conjugate vaccine (PCV) serotypes in southern Israel shortly after sequential introduction of 7-valent/13-valent PCV.